Dr. Zaid Alirhayim, MD

Dr. Alirhayim practices at Missouri Delta Medical Center in Sikeston, Missouri, part of Missouri Delta Medical Center.

Dr. Alirhayim's NPI, 1578842910, was assigned on August 16, 2011. Dr. Alirhayim graduated from Arabian Gulf University College of Medicine in 2009. Dr. Alirhayim's Oklahoma license number on file is 32904.

Dr. Alirhayim's primary practice is Missouri Delta Medical Center, at 1008 North Main St, Sikeston, MO 63801 in Scott County. The practice phone is (573) 472-7586.

Dr. Alirhayim's primary practice is Missouri Delta Medical Center in Sikeston, Missouri, part of Missouri Delta Medical Center. Dr. Alirhayim is also affiliated with Saint Francis Medical Center. The medical group on file is Missouri Delta Medical Center. Dmand AI also links Dr. Alirhayim to 3 more hospitals, 4 medical groups and 2 group practices and clinics, each named with a free account. Dr. Alirhayim's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Alirhayim practices, 7 sites in all. Vendor and product names are available with a free account.

Interventional cardiology is Dr. Alirhayim's primary specialty in the NPI Registry, under taxonomy code 207RI0011X. Dr. Alirhayim is board certified in cardiovascular disease by the American Board of Internal Medicine. Dmand AI has Dr. Alirhayim's licenses on file in 10 states: Oklahoma, Ohio, Arizona, Missouri, Arkansas, Minnesota, Washington, Wisconsin, Hawaii and Michigan.

CMS data shows 505 Medicare services from Dr. Alirhayim across 14 procedure codes in 2024, for 288 Medicare patients. Medicare paid $28,776 for them.

CMS counts 288 Medicare patients who saw Dr. Alirhayim in 2024. The largest group is 75 to 84, with 126 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 10% are also on Medicaid. Their average risk score is 1.32, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Alirhayim's median patient age at 72, with 51% women.

In 2024, Dr. Alirhayim wrote 242 Medicare Part D claims for 86 patients. 87% of them were for generic drugs. CMS names the drug for 166 of them, across 7 drugs with 11 or more claims each, at $12,736 in total drug cost. In 2019, CMS named 353 claims across 11 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 87 out of 100 for Dr. Alirhayim for performance year 2024, reported as part of a group. Dr. Alirhayim accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Alirhayim as offering telehealth. CMS counts 13 procedures of coronary angioplasty and stenting by Dr. Alirhayim, more than 35% of the clinicians it reports for that procedure.

Pacemaker insertion or repair: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 39 papers to Dr. Alirhayim, published from 2012 to 2025. 2013 was the busiest year, with 9. The most frequent topics are Atrial Fibrillation, Warfarin and Anticoagulants. Dr. Alirhayim has published most often in Circulation. Dr. Alirhayim's most frequent co-authors are Waqas T. Qureshi, MBBS, MD, Fatima Rizwan Khalid, MD and Mouaz H. Al-Mallah, MD.

CMS Open Payments shows 152 general payments to Dr. Alirhayim from 18 drug and device companies from 2016 to 2025. Grants make up the largest share, 48% of the total. Abbott Laboratories paid the most, $14,288.

Dmand AI lists 6 awards for Dr. Alirhayim, most recently American Association for Cancer Research Scholar-in-Training Award in 2013.

Dr. Alirhayim graduated from Arabian Gulf University College of Medicine in 2009. Dr. Alirhayim is a member of ACP.

Dr. Alirhayim is in network with 24 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 14. Check the plan with the practice before a visit.